<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139560">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01917682</url>
  </required_header>
  <id_info>
    <org_study_id>PRECISION CorPath Registry</org_study_id>
    <nct_id>NCT01917682</nct_id>
  </id_info>
  <brief_title>Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions</brief_title>
  <acronym>PRECISION</acronym>
  <official_title>A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corindus Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corindus Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to collect additional information on the safety and
      effectiveness of the CorPath 200 system now that it is cleared for use by physicians in the
      delivery and manipulation of coronary guidewires and balloons/stents during percutaneous
      coronary interventions.  The study is designed to collect information from the routine use
      of the CorPath 200 system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-arm, open-label, multi-center patient registry of the CorPath
      200 System to examine its performance during PCI procedure and patient outcomes through 72
      hours post-procedure or hospital discharge, whichever occurs first.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>3 Days</target_duration>
  <primary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>In-hospital (72 hours or discharge, whichever occurs first)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Less than 30% residual stenosis post PCI in the lesion(s) treated with the CorPath system, without in-hospital major adverse coronary events (MACE).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-hospital Major Adverse Coronary Events (MACE)</measure>
    <time_frame>In-hospital (72 hours or discharge, whichever occurs first)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The composite of death, myocardial infarction, and target vessel revascularization that occurs within 72 hours of the procedure or prior to hospital discharge, whichever occurs first, in a subject treated with the CorPath 200 System.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>In-hospital (72 hours or discharge, whichever occurs first)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>All Serious Adverse Events (SAEs) and Unanticipated Adverse Device Effects (UADEs) from the start of the CorPath procedure until the end of the study will be summarized.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Overall Procedure Time</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Defined as the time measured from the insertion of the hemostasis sheath until the removal of the guide catheter.</description>
  </other_outcome>
  <other_outcome>
    <measure>PCI Procedure Time</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.</description>
  </other_outcome>
  <other_outcome>
    <measure>Fluoroscopy and/or X-Ray Time</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>As recorded by an X-Ray System utilized during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Radiation Exposure</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>DAP (dose-area-product) and cumulative dose as recorded during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast Fluid Volume</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>No additional description</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Conversions to Manual</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>The overall number of conversions from the robotic PCI to manual PCI will be captured to analyze the technical success of the device.</description>
  </other_outcome>
  <other_outcome>
    <measure>Measurement of Lesion and Stented Segment Length</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual estimate by clinical operator prior to delivery of PCI device(s).
CorPath 200 System measurement of the segment planned for treatment and length of deployed stent.
Quantitative Coronary Angiography (QCA) of stented segment length</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <condition>Heart Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Arteriosclerosis</condition>
  <condition>Arterial Occlusive Diseases</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Study Cohort</arm_group_label>
    <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CorPath-assisted Percutaneous Coronary Intervention</intervention_name>
    <description>Robotic-assisted Percutaneous Coronary Intervention</description>
    <arm_group_label>Study Cohort</arm_group_label>
    <other_name>Robotic-assisted Percutaneous Coronary Intervention</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with coronary artery disease and with the clinical indication for Percutaneous
        Coronary Intervention (PCI).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;18 years.

          2. Patients with coronary artery disease undergoing Percutaneous Coronary Intervention
             (PCI) with the CorPath 200 system.

          3. The subject or the legal representative has been informed of the nature of the study,
             agrees to its provisions and has provided written informed consent.

        Exclusion Criteria:

          1. Concurrent enrollment in another device or drug study protocol that specifically
             excludes concurrent enrollment or that prevents collection of data required in this
             registry (concurrent participation in another registry is not an automatic exclusion
             criterion for this study).

          2. Failure/inability/unwillingness to provide informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giora Weisz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University Medical Center/New York-Presbyterian Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patricia Dizon</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Project Manager, Corindus Vascular Robotics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tal Wenderow</last_name>
    <role>Study Director</role>
    <affiliation>Co-Founder &amp; Executive VP, Corindus Vascular Robotics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Dizon, Clinical Project Manager</last_name>
    <phone>(508) 653-3335</phone>
    <phone_ext>264</phone_ext>
    <email>patricia.dizon@corindus.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ehtisham Mahmud, MD</last_name>
      <email>emahmud@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Ehtisham Mahmud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mitul Patel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley View Hospital</name>
      <address>
        <city>Glenwood Springs</city>
        <state>Colorado</state>
        <zip>81601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richelle (Shelley) Reed, RN</last_name>
      <phone>970-384-7282</phone>
      <email>richelle.reed@vvh.org</email>
    </contact>
    <investigator>
      <last_name>Frank A. Laws, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kimberly Johnson, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlando Regional Medical Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vijaykumar Kasi, MD</last_name>
      <email>vijaykasimd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vijaykumar Kasi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeast Georgia Heart Center</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Patrick, RN</last_name>
      <phone>678-989-5001</phone>
      <email>dpatrick@ngheartcenter.com</email>
    </contact>
    <investigator>
      <last_name>Mark Leimbach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pradyumna Tummala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Marshall, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Joseph P. Carrozza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Detroit Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Theodore Schreiber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospital Group</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jennifer Schuitema, MA</last_name>
      <phone>616-391-6660</phone>
      <email>Jennifer.Schuitema@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>David Wohns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital Center</name>
      <address>
        <city>Liverpool</city>
        <state>New York</state>
        <zip>13088</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Lastinger, RN</last_name>
      <phone>315-448-6215</phone>
      <email>clastinger@sjhcardiology.org</email>
    </contact>
    <investigator>
      <last_name>Ron Caputo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Fischi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ayman Iskander, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Simons, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/New York-Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andy Morales</last_name>
      <phone>212-342-4357</phone>
      <email>am2513@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Moses, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ali Aboufares, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamim Nazif, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manish Parikh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Campbell, MD</last_name>
      <email>paul.campbell@carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Paul Campbell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiram Bezerra, MD</last_name>
      <email>hiram.bezerra@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Hiram Bezerra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Health</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Wittrock</last_name>
      <phone>605-312-2346</phone>
      <email>amy.wittrock@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Tomasz Stys, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Stys, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marian Petrasko, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.corindus.com</url>
    <description>Visit the Corindus website for related information.</description>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>August 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robotic-assisted PCI</keyword>
  <keyword>coronary intervention</keyword>
  <keyword>CorPath PRECISION Registry</keyword>
  <keyword>PCI</keyword>
  <keyword>angioplasty</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
